迈瑞医疗收盘下跌3.30%，滚动市盈率23.56倍，总市值2623.84亿元

Group 1 - The core viewpoint of the articles highlights that Mindray Medical's stock closed at 216.41 yuan, down 3.30%, with a rolling PE ratio of 23.56 times and a total market capitalization of 262.38 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 51.42 times and a median of 37.44 times, Mindray Medical ranks 52nd in terms of PE ratio [1] - As of the first quarter of 2025, a total of 323 institutions hold shares in Mindray Medical, including 315 funds, with a total shareholding of 93,763.20 million shares valued at 219.41 billion yuan [1] Group 2 - Mindray Medical's main business includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - The latest performance report for the first quarter of 2025 shows that the company achieved operating revenue of 8.24 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.63 billion yuan, down 16.81% year-on-year, with a gross profit margin of 62.53% [1] - The PE ratios for Mindray Medical are 23.56 (TTM) and 22.49 (static), with a price-to-book ratio of 6.80 [2]